Stock Market Tips, Nifty opens Diwali week at record high hits 10,200; Sensex up 200 pts

• We are offering 2 days free trial pack in all equity segments with the stock recommendation. So for that visit our site and fill a free trial Stock Advisory in Indore

Shares of Glenmark Pharma added 1 percent in the morning as it has received approval for Aprepitant Capsules.

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Aprepitant Capsules USP 40 mg, 80 mg, and 125 mg.

Aprepitant Capsules USP is a generic version of Emend Capsules, 40 mg, 80 mg, and 125 mg, of Merck Sharp & Dohme Corporation.

As per IMS Health sales data for the 12 month period ending August 2017, the Emend Capsules achieved annual sales of approximately USD 64.9 million.